Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEAPOT: Nebulized Tranexamic Acid for Pediatric Post-Operative Tonsillectomy Hemorrhage
NCT06580509Phase 1Recruiting
- Sponsor
- UT Health San Antonio
- Start
- Feb 2026
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of tranexamic acid in Post-Tonsillectomy Hemorrhage (PTH) (2 arms), sponsored by UT Health San Antonio. Primary endpoints: Number of patients enrolled per month at 18 months, Number of nebulizations per patient at 18 months and 2 more. Started Feb 2026; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
Post-Tonsillectomy Hemorrhage (PTH)
Beyond the preview
Go deeper on NCT06580509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06580509.